A forty-year-old female with no significant past medical history presented to the emergency department with peritonitis and subsequently underwent a laparotomy and sub-total colectomy for toxic megacolon. She was admitted to the intensive care unit (ICU) postoperatively where she was treated for septic shock. The initial histopathology was suggestive of a new diagnosis of Crohn's disease.
Shortly after ICU admission, she developed a right-sided basal pneumonia and bronchoalveolar lavage (BAL) samples were found to be persistently positive for Aspergillus fumigatus. Thoracic computed tomography (CT) revealed widespread cavitating lesions. Bronchoscopic transbronchial biopsy of an area of consolidation was also performed, with microscopy confirming a diagnosis of invasive aspergillosis (IA). Treatment with liposomal amphotericin B and voriconazole was commenced and the patient' s condition initially began to improve, although mechanical ventilation was still required. Throughout this time right lower lobe consolidation remained evident on plain chest radiographs.
Unfortunately the patient' s condition once again deteriorated, with increasing levels of respiratory support being required. At this stage, the consolidation also appeared to worsen, and a bronchoscopy was performed which showed a new right lower lobe mass. The patient was listed for a rigid bronchoscopy and surgical biopsy of this mass. At the time of biopsy, the mass was found to be pulsatile, and biopsy was abandoned. A CT angiogram of the pulmonary vessels confirmed the presence of a two centimetre pseudoaneurysm of the right medial basal segmental pulmonary artery (Figure 1 ).
It was decided that endovascular coil embolisation of the pseudoaneurysm would be the safest approach. This was achieved using access from the right common femoral vein, allowing cannulation of the pulmonary artery using a guidewire and catheter. The 'parent' vessels of the aneurysm sac were then embolised. The distal ('back door') vessel was embolised using coils to prevent back-filling of the aneurysm sac. The proximal ('front door') vessel was then embolised with an occlusion plug. Completion angiography demonstrated successful exclusion of the pseudoaneurysm (Figure 2, 3 and 4 ).
Pulmonary artery aneurysm caused by Aspergillus pneumonia presenting as an endobronchial mass lesion 3G00
We present a case of pulmonary artery aneurysm (PA aneurysm) following Aspergillus fumigatus pneumonia treated by coil embolisation. Although rare, PA aneurysms have a high mortality rate with a large proportion of the cases reported being found at post-mortem examination. Aspergillus infection is known to result in aneurysms in immunocompromised patients and in patients with infective endocarditis. The case we report is unusual in that the patient was not obviously immunocompromised, and initially presented with a different pathology. Treatment by endovascular coil embolisation was successfully employed in this instance, allowing the patient to be weaned from ventilatory support. Although this is an unusual complication of Aspergillus pneumonia, the identification and successful treatment of pulmonary artery aneurysms requires a high-index of suspicion. The procedure was carried out under general anaesthesia with the use of a left-sided double lumen endotracheal tube in order to protect the left lung in the event of significant pulmonary haemorrhage.
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Following a long period of hospitalisation and pulmonary rehabilitation the patient was discharged home where she continues to make a steady recovery on long-term voriconazole therapy.
Discussion
Aspergillus species are ubiquitous moulds found in organic matter. The majority of human illness is caused by Aspergillus fumigatus. The transmission of fungal spores to the human host is typically via inhalation to the lungs where it presents with a spectrum of clinical syndromes. Invasive aspergillosis can be diagnosed after culture from blood or fluid/tissue from an otherwise sterile area (excluding BAL fluid, urine, or cranial sinus cavity fluid), or from microscopic identification of Aspergillus in tissue accompanied by evidence of associated tissue damage. 1 IA is a severe disease and is well described, especially in immunocompromised patients with haematological malignancy. The incidence of IA in immunocompetent ICU patients is unclear, but may be between 0.3% and 19% of all ICU patients. [2] [3] IA should be considered in critically ill ICU patients with pneumonia where Aspergillus has been isolated from bronchial secretions. IA in critically ill patients without malignancy has a reported mortality of greater than 80%. [4] [5] Aneurysm formation associated with IA is most commonly described as occurring within the aorta, carotid, and intracranial arteries. [6] [7] PA aneurysms associated with IA have occasionally been described in patients who are immunosuppressed with haematological malignancy, but there are very few reports of them occurring in immunocompetent adults.
PA aneurysms were described as early as the 1700s, and can be congenital or acquired, with infection being the most common acquired cause. In the pre-antibiotic era, many aneurysms were thought to be due to tuberculosis and syphilis as well as staphylococcal and streptococcal infections. The use of antibiotics has been associated with a decrease in the incidence of PA aneurysms, such that it is now a very rare phenomenon. 8 Although the true incidence is unknown, a review in 1947 by Geterling and Clagett found only eight cases of PA aneurysms were documented in over 109,000 autopsies. [9] [10] The most common description of PA aneurysms associated with fungal infections is in patients with endocarditis, where endovascular seeding causes vessel infection; the same is true for PA aneurysms associated with intravenous (IV) drug abuse. 11 Our patient had no history of IV drug use, and there was no evidence of endocarditis. Endovascular seeding in cases of pneumonia has been described, as has contiguous spread from within consolidated lung, with the fungus invading the vessel outer wall and spreading medially (sometimes called a Rasmussen aneurysm). 9, 11 It is this latter method of invasion that was most likely to have occurred in this case.
Once identified, the decision to proceed to endovascular coil embolisation in preference to a surgical lobectomy was made on the grounds that the patient' s respiratory condition was unstable and would be less able to tolerate open surgery. Endovascular embolisation of PA aneurysms has been reported several times in the literature using a number of different agents. Coils, glue, occluder plugs and covered stents have all been used in the pulmonary tree successfully; the choice of embolic agent however is highly dependent on the number, size and location of the lesion(s). [12] [13] [14] The mortality associated with surgical or conservative management of PA aneurysms is known to be high. Complications secondary to embolisation are thought to be less frequent, and include contrast-induced nephropathy, arterial dissection and pulmonary infarction.
Having a high index of suspicion of a PA aneurysm is essential, as reported cases have often been found at postmortem. There have been four previous case reports of PA aneurysms presenting as an endobronchial mass lesions, and in all four cases the patients haemorrhaged during biopsy and did not survive. 15
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